These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 10465084)

  • 1. Tuberculosis preventive therapy in people living with HIV in sub-Saharan Africa.
    Godfrey-Faussett P
    AIDS; 1999 Aug; 13(12):1581-2. PubMed ID: 10465084
    [No Abstract]   [Full Text] [Related]  

  • 2. Tuberculosis preventive therapy for HIV-infected people in sub-Saharan Africa is cost-effective.
    Bell JC; Rose DN; Sacks HS
    AIDS; 1999 Aug; 13(12):1549-56. PubMed ID: 10465080
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The HIV-associated tuberculosis epidemic--when will we act?
    Harries AD; Zachariah R; Corbett EL; Lawn SD; Santos-Filho ET; Chimzizi R; Harrington M; Maher D; Williams BG; De Cock KM
    Lancet; 2010 May; 375(9729):1906-19. PubMed ID: 20488516
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The double burden of HIV infection and tuberculosis in sub-Saharan Africa.
    Msamanga GI; Fawzi WW
    N Engl J Med; 1997 Sep; 337(12):849-51. PubMed ID: 9295244
    [No Abstract]   [Full Text] [Related]  

  • 5. Preventive treatment for tuberculosis in people with HIV.
    Swaminathan S
    Lancet; 2014 Aug; 384(9944):644-6. PubMed ID: 24835843
    [No Abstract]   [Full Text] [Related]  

  • 6. Issues facing TB control (6). Tuberculosis control in sub-Saharan Africa in the face of HIV and AIDS.
    Harries AD
    Scott Med J; 2000 Oct; 45(5 Suppl):47-50; discussion 51. PubMed ID: 11130317
    [No Abstract]   [Full Text] [Related]  

  • 7. Questions about a placebo-controlled trial of preventive therapy for tuberculosis in HIV-infected Ugandans.
    Desvarieux M
    N Engl J Med; 1998 Mar; 338(12):841; author reply 842-3. PubMed ID: 9508639
    [No Abstract]   [Full Text] [Related]  

  • 8. Isoniazid prevented active tuberculosis in patients with HIV treated with antiretroviral therapy.
    Sacks HS
    Ann Intern Med; 2014 Sep; 161(6):JC12. PubMed ID: 25222412
    [No Abstract]   [Full Text] [Related]  

  • 9. Questions about a placebo-controlled trial of preventive therapy for tuberculosis in HIV-infected Ugandans.
    Turner MT
    N Engl J Med; 1998 Mar; 338(12):841-2. PubMed ID: 9508640
    [No Abstract]   [Full Text] [Related]  

  • 10. Preventive therapy against tuberculosis in people living with HIV.
    Wkly Epidemiol Rec; 1999 Nov; 74(46):385-98. PubMed ID: 10611855
    [No Abstract]   [Full Text] [Related]  

  • 11. Southern Africa is moving swiftly to combat the threat of XDR-TB.
    Wise J
    Bull World Health Organ; 2006 Dec; 84(12):924-5. PubMed ID: 17242824
    [No Abstract]   [Full Text] [Related]  

  • 12. Isoniazid prophylaxis for high-risk patients with anergy and HIV infection.
    Aguado JM; Pulido F; Moreno S
    N Engl J Med; 1997 Dec; 337(23):1696-7; author reply 1697. PubMed ID: 9411240
    [No Abstract]   [Full Text] [Related]  

  • 13. The sound of one hand clapping: tuberculosis and antiretroviral therapy in Africa.
    De Cock KM; Marston B
    Am J Respir Crit Care Med; 2005 Jul; 172(1):3-4. PubMed ID: 15980107
    [No Abstract]   [Full Text] [Related]  

  • 14. Isoniazid prophylaxis for high-risk patients with anergy and HIV infection.
    Dore GJ; Law MG; Kaldor JM
    N Engl J Med; 1997 Dec; 337(23):1697. PubMed ID: 9411241
    [No Abstract]   [Full Text] [Related]  

  • 15. Prevention of tuberculosis in HIV-infected patients.
    Nahid P; Daley CL
    Curr Opin Infect Dis; 2006 Apr; 19(2):189-93. PubMed ID: 16514345
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chemoprophylaxis for tuberculosis in HIV-infected individuals in sub-Saharan Africa.
    Nuwaha F
    East Afr Med J; 1998 Sep; 75(9):520-7. PubMed ID: 10493054
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tuberculosis in the AIDS era.
    Ellenbogen C
    N C Med J; 1993 Jan; 54(1):9-14. PubMed ID: 8426665
    [No Abstract]   [Full Text] [Related]  

  • 18. How human immunodeficiency virus voluntary testing can contribute to tuberculosis control.
    Godfrey-Faussett P; Maher D; Mukadi YD; Nunn P; Perriëns J; Raviglione M
    Bull World Health Organ; 2002; 80(12):939-45. PubMed ID: 12571721
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Factors associated with patient and health care system delay in diagnosis and treatment for TB in sub-Saharan African countries with high burdens of TB and HIV.
    Finnie RK; Khoza LB; van den Borne B; Mabunda T; Abotchie P; Mullen PD
    Trop Med Int Health; 2011 Apr; 16(4):394-411. PubMed ID: 21320240
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Modelling the economic benefits of tuberculosis preventive therapy for people with HIV: the example of Zambia.
    Foster S; Godfrey-Faussett P; Porter J
    AIDS; 1997 Jun; 11(7):919-25. PubMed ID: 9189218
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.